ENGLISH
|
JAPANESE
|
CONNECT WITH US:
Home
About
Contact
Log in
*
Home
Press release
Oct 29, 2021 10:19 JST
Source:
Mitsubishi Heavy Industries, Ltd.
MHI Invests in Cemvita Factory, Inc., a Leading Industrial Biotechnology Startup, to Accelerate Decarbonization Efforts
The partnership contributes to MHI's strategic focus on identifying and accelerating decarbonization opportunities through investments in renewable projects and climate tech startups
TOKYO, Oct 29, 2021 - (JCN Newswire) - Mitsubishi Heavy Industries (MHI) Group today announced that it has invested in Cemvita Factory, Inc. (Cemvita), a Houston-based startup that utilizes innovative synthetic biology to decarbonize heavy industries such as chemical manufacturing, mining, and oil and gas. By investing in Cemvita's business expansion, MHI continues to deliver on its strategy to identify and accelerate decarbonization opportunities through investments in renewable projects and climate tech startups.
MHI Group is committed to building an innovative solutions ecosystem to realize a carbon-neutral future. This includes strengthening its decarbonization technology offerings and developing a carbon dioxide (CO2) ecosystem that is central to those initiatives. Carbon capture, utilization and storage solutions are increasingly viewed as effective means to realizing a carbon-neutral society, and Cemvita's technology is one of many solutions needed to achieve it.
"At MHI we are committed to accelerating decarbonization. We believe there is not only one technology to be utilized, but that it is necessary to combine multiple technologies to achieve our world's carbon net-zero goals," said Yoshihiro Shiraiwa, President and CEO of Mitsubishi Heavy Industries America. "We must work closely with new and existing partners to develop new business models that advance our goals for decarbonization."
Cemvita provides innovative CO2 utilization solutions through biotechnology for heavy industries. Its bio-manufacturing platform mitigates emissions from traditionally energy-intensive chemical and catalytic conversion processes by operating under ambient temperature and pressure. Additionally, this same technology can turn polymer production into a low-carbon activity by utilizing CO2 as a feedstock, a crucial step in building a circular carbon economy.
"We are excited to have Cemvita supported by strong corporate partners like MHI, who has extensive engineering capabilities across heavy industry markets," said Cemvita Factory Co-Founder and CEO Moji Karimi. "This capital will accelerate our growth and scale our carbon negative solutions to fight climate change."
The investment has been executed through Mitsubishi Heavy Industries America, Inc. MHI joins a consortium of investors, including Energy Capital Ventures and Sumitomo Corporation of America.
About Cemvita Factory, Inc.
Cemvita Factory, Inc, is on a mission to reverse climate change by leveraging synthetic biology. This is done by leveraging the biomimicry of natural processes to sustainably produce chemicals and polymers. Additionally, Cemvita's synthetic biology platform is used to develop and optimize low carbon bioprocesses for heavy industry such as mining and oil and gas. Visit www.cemvitafactory.com for more information.
About MHI Group
Mitsubishi Heavy Industries (MHI) Group is one of the world's leading industrial groups, spanning energy, logistics & infrastructure, industrial machinery, aerospace and defense. MHI Group combines cutting-edge technology with deep experience to deliver innovative, integrated solutions that help to realize a carbon neutral world, improve the quality of life and ensure a safer world. For more information, please visit www.mhi.com or follow our insights and stories on www.spectra.mhi.com.
Source: Mitsubishi Heavy Industries, Ltd.
Sectors: Energy, Alternatives, Alternative Energy
Copyright ©2024 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.
Latest Release
Toyota Exhibiting at Beijing Motor Show 2024
Apr 25, 2024 16:25 JST
Honda Reaches Basic Agreement with Asahi Kasei on Collaboration for Production of Battery Separators for Automotive Batteries in Canada
Apr 25, 2024 11:10 JST
UNIQLO Sponsors KAWS + Warhol Exhibition Tour, Starting in Pittsburgh
Apr 25, 2024 09:00 JST
Mitsubishi Power Begins Commercial Operation of Seventh M701JAC Gas Turbine in Thailand GTCC Project; Achieves 75,000 AOH To-Date
Apr 24, 2024 17:19 JST
MC and Denka Sign J/V Agreement in Fullerene Business
Apr 24, 2024 17:02 JST
Mitsubishi Motors Posts Record Sales in the Philippines in FY2023
Apr 24, 2024 13:56 JST
NEC Develops High-speed Generative AI Large Language Models (LLM) with World-class Performance
Apr 24, 2024 13:25 JST
Fujitsu SX Survey reveals key success factors for sustainability
Apr 23, 2024 10:25 JST
Fujitsu and METRON collaborate to drive ESG success: slashing energy costs, boosting productivity with new manufacturing industry solutions
Apr 22, 2024 16:09 JST
NEC Strengthens Commitment to Space Industry with Investment in Seraphim Space Venture Fund II
Apr 22, 2024 15:09 JST
Soft Space Launches the First and Only JCB Payment Gateway in Malaysia
Apr 22, 2024 15:00 JST
TOYOTA GAZOO Racing takes a one-two in Croatian thriller
Apr 22, 2024 10:47 JST
First-ever Mazda CX-80 Crossover SUV Unveiled in Europe
Apr 19, 2024 13:50 JST
Fujitsu develops technology to convert corporate digital identity credentials, enabling participation of non-European companies in European data spaces
Apr 19, 2024 10:17 JST
Mitsubishi Heavy Industries and NGK to Jointly Develop Hydrogen Purification System from Ammonia Cracking Gas
Apr 18, 2024 17:01 JST
Toyota Launches All-New Land Cruiser "250" Series in Japan
Apr 18, 2024 13:39 JST
Fujitsu and Oracle collaborate to deliver sovereign cloud and AI capabilities in Japan
Apr 18, 2024 11:14 JST
Eisai: Research on Treatments for Alzheimer's Disease Based on Its Pathological Mechanisms Recieves Award for Science and Technology (Research Category)
Apr 18, 2024 10:53 JST
All-New Triton Confirmed as First Double-Cab Pickup Truck to Achieve 2024 Five-Star ANCAP Safety Rating
Apr 18, 2024 09:22 JST
Eisai's Antiepileptic Drug Fycompa Injection Formulation Launched In Japan
Apr 17, 2024 16:17 JST
More Latest Release >>
Related Release
Mitsubishi Heavy Industries and NGK to Jointly Develop Hydrogen Purification System from Ammonia Cracking Gas
4/18/2024 5:01:00 PM JST
Heidelberg Materials North America Announces Latest Milestone in Edmonton CCUS Project
4/12/2024 2:39:00 PM JST
MHIAEL Completes Expansion of the its Nagasaki Plant for Manufacture of Aero Engine Combustors
4/11/2024 6:08:00 PM JST
Mitsubishi Shipbuilding Acquires Approval in Principle (AiP) from Classification Society ClassNK for Ammonia Fuel Supply System (AFSS)
4/11/2024 5:50:00 PM JST
Mitsubishi Shipbuilding Receives Order for Ammonia Fuel Supply System for Ammonia-Powered Marine Engine
4/10/2024 4:55:00 PM JST
Mitsubishi Power Receives Order from HK Electric for Natural-gas-fired GTCC Power Generation Equipment
4/9/2024 3:04:00 PM JST
MHI Thermal Systems Adds New KXZ3 Series of Building-use Multi-Split Air- Conditioners Adopting R32 Refrigerant
4/9/2024 1:40:00 PM JST
MHI Concludes Positive Impact Finance Agreement
3/29/2024 7:20:00 PM JST
Mitsubishi Shipbuilding Receives Order from the University of Tokyo for "MiPoLin" Power Prediction and Lines Selection System
3/28/2024 4:45:00 PM JST
Mitsubishi Logisnext Completes Demonstration of Automated Truck Loading, Leading to Start of Actual Operations in Japan
3/28/2024 1:52:00 PM JST
More Press release >>